Zhang Y - Search Results

1

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer.

Peng Y, Yu H, Jin Y, Qu F, Ren H, Tang Z, Zhang Y, Qu C, Zong B, Liu S. Peng Y, et al. Among authors: zhang y. Front Immunol. 2021 Apr 27;12:666137. doi: 10.3389/fimmu.2021.666137. eCollection 2021. Front Immunol. 2021. PMID: 33986754 Free PMC article.

2

Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast Carcinoma.

Wu Q, Yin G, Luo J, Zhang Y, Ai T, Tian J, Jin Y, Lei J, Liu S. Wu Q, et al. Among authors: zhang y. Front Endocrinol (Lausanne). 2021 Jul 26;12:665666. doi: 10.3389/fendo.2021.665666. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34381422 Free PMC article.

3

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.

Peng Y, Yu H, Zhang Y, Qu F, Tang Z, Qu C, Tian J, Zong B, Wang Y, Ren H, Liu S. Peng Y, et al. Among authors: zhang y. Sci Rep. 2021 Sep 2;11(1):17610. doi: 10.1038/s41598-021-97102-z. Sci Rep. 2021. PMID: 34475496 Free PMC article.

4

JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer.

Peng Y, Li H, Fu Y, Guo S, Qu C, Zhang Y, Zong B, Liu S. Peng Y, et al. Among authors: zhang y. Int Immunopharmacol. 2022 Feb;103:108430. doi: 10.1016/j.intimp.2021.108430. Epub 2021 Dec 17. Int Immunopharmacol. 2022. PMID: 34923424

5

A look into the link between centrosome amplification and breast cancer.

Zhang Y, Tian J, Qu C, Peng Y, Lei J, Sun L, Zong B, Liu S. Zhang Y, et al. Biomed Pharmacother. 2020 Dec;132:110924. doi: 10.1016/j.biopha.2020.110924. Epub 2020 Oct 28. Biomed Pharmacother. 2020. PMID: 33128942 Free article. Review.

6

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis.

Zhang Y, Tian J, Qu C, Tang Z, Wang Y, Li K, Yang Y, Liu S. Zhang Y, et al. Medicine (Baltimore). 2020 Dec 4;99(49):e23359. doi: 10.1097/MD.0000000000023359. Medicine (Baltimore). 2020. PMID: 33285715 Free PMC article.

7

Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.

Zhang Y, Tian J, Qu C, Peng Y, Lei J, Li K, Zong B, Sun L, Liu S. Zhang Y, et al. Breast Cancer. 2021 Jul;28(4):859-873. doi: 10.1007/s12282-021-01221-4. Epub 2021 Feb 10. Breast Cancer. 2021. PMID: 33569740 Free PMC article.

8

HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance.

Zong B, Sun L, Peng Y, Wang Y, Yu Y, Lei J, Zhang Y, Guo S, Li K, Liu S. Zong B, et al. Among authors: zhang y. Oncol Rep. 2021 Jul;46(1):138. doi: 10.3892/or.2021.8089. Epub 2021 May 26. Oncol Rep. 2021. PMID: 34036395 Free PMC article.

9

[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance.

Zong B, Sun L, Peng Y, Wang Y, Yu Y, Lei J, Zhang Y, Guo S, Li K, Liu S. Zong B, et al. Among authors: zhang y. Oncol Rep. 2021 Sep;46(3):195. doi: 10.3892/or.2021.8146. Epub 2021 Jul 23. Oncol Rep. 2021. PMID: 34296290 Free PMC article.

10

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia.

Liu Y, Wang G, Zhang J, Chen X, Xu H, Heng G, Chen J, Zhao Y, Li J, Ni Y, Zhang Y, Shan J, Qian C. Liu Y, et al. Among authors: zhang j, zhang y. Stem Cell Res Ther. 2021 Jan 25;12(1):86. doi: 10.1186/s13287-021-02155-6. Stem Cell Res Ther. 2021. PMID: 33494824 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256,247 results

Search Page

Filters